432 filings
Page 8 of 22
8-K
1vp0dq2l
3 Aug 09
Human Genome Sciences Announces Pricing of Public Offering of Common Stock
12:00am
424B5
h544jexx39spz70
29 Jul 09
Prospectus supplement for primary offering
12:00am
424B5
indfggjo
27 Jul 09
Prospectus supplement for primary offering
12:00am
8-K
9d6l4mag2y
27 Jul 09
Other Events
12:00am
8-K
lg9vvrhjv 9ptlk18r
23 Jul 09
Human Genome Sciences Announces New Order for Raxibacumab (Abthrax™) from U.s. Government
12:00am
CT ORDER
vq91wh2 qs5ncld96c
29 Jun 09
Confidential treatment order
12:00am
S-8
n4i3r xq6
6 May 09
Registration of securities for employees
12:00am
EFFECT
lxw6r8i82f71gzzcq4
4 May 09
Notice of effectiveness
12:00am
8-K
1ebi78dg5zm efdtem
29 Apr 09
Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments
12:00am
CT ORDER
0jf7c0kdr y8
1 Apr 09
Confidential treatment order
12:00am
DEFR14A
wk0 ywg56iry98zm4e
31 Mar 09
Revised proxy
12:00am
UPLOAD
ds2csp
20 Mar 09
Letter from SEC
12:00am
CORRESP
gpq7hu6vcts1alu10
10 Mar 09
Correspondence with SEC
12:00am
8-K
oxj906vo
26 Feb 09
Human Genome Sciences Announces Fourth-quarter and Full-year 2008 Financial Results and Key Developments
12:00am
UPLOAD
ekxl1h
25 Feb 09
Letter from SEC
12:00am